Oncologists debate the proper treatment of a patient with a grade 2 endometrial carcinoma tumor.
Bradley Monk, MD, FACOG, FACS
Advertisement
Articles by Bradley Monk, MD, FACOG, FACS
Physician-researchers discuss the risk of recurrence in endometrial carcinoma and the available treatment options after relapse.
An overview of biomarker testing in endometrial carcinoma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma
2
Dr Wainberg on INCB161734 Activity in Refractory Pancreatic Cancer
3
European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma
4
ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer
5